Last Price$2.61Cboe Real-Time Last Sale as of 11:03AM ET 1/31/23
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.06(2.16%)
Bid (Size)$2.60 (800)
Ask (Size)$2.61 (1,000)
Day Low / High$2.57 - 2.65
Volume451.2 K

Agenus Starts Phase 2 Trials of Botensilimab for Colorectal Cancer, Advanced Melanoma

10:45AM ET 9/12/2022 MT Newswires
Agenus (AGEN) said Monday it has started separate phase 2 trials, the Activate-Colorectal and the Activate-Melanoma, evaluating botensilimab as a potential treatment for colorectal cancer and advanced melanoma.

The Activate-Colorectal study will test the safety and efficacy of botensilimab as a standalone therapy or in combination with balstilimab for the treatment of microsatellite stable colorectal cancer, the company said.

Meanwhile, the Activate-Melanoma study will evaluate the safety and efficacy of the drug candidate as a single agent for advanced melanoma.

The company expects to launch an additional phase 2 study in pancreatic cancer later this year.